Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

Université de Montréal

$17,500.00

Investigating the contribution of methionine metabolism in the development of drug resistance by modulating chromatin landscapes

FY 2020-21

Summary
Triple negative breast cancer (TNBC) is an aggressive form of breast cancer that has a poor prognosis due to the high incidence of resistance to chemotherapy drugs. Drug resistance acquired in cancer cells is partly related to changes in cell metabolism and in gene regulation. Certain chemical changes that take place in DNA in the nucleus of the cell are called epigenetic changes and control which genes are expressed or not. These epigenetic processes are modulated by the availability of certain nutrients in the cell, called metabolites. While the availability of some of these metabolites can induce epigenetic changes and thus influence gene expression, epigenetic changes can in turn also control the levels and use of metabolites. This inter-regulation allows the tumour to adapt and survive in the context of a new environment, such as that resulting from exposure to drugs. The main objective of our research is to understand how metabolic and epigenetic changes regulate each other in drug-resistant TNBC in order to identify new ways to re-sensitize TNBC cells to chemotherapy. We have developed TNBC cells that are resistant to paclitaxel, a standard treatment drug for patients with TNBC. We are interested in understanding the role of methionine, an essential nutrient in the diet, in drug resistance. This is because drug resistant TNBC cells use more methionine than drug sensitive cells. We aim to identify how changes in methionine use in drug-resistant TNBC cells impact the production and use of other metabolites in order to identify potential vulnerabilities in resistant cells. We will also assess how these changes in methionine use contribute to altering epigenetic modifications and what the impact is on gene expression in paclitaxel-resistant TNBC cells.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
449624
Name
Bouchard Pascale
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the contribution of methionine metabolism in the development of drug resistance by modulating chromatin landscapes
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Breast Cancer; Breast Cancer Resistance; Cancer Therapy; Cell Biology; Chemotherapy; Epigenetics; Metabolomics; Molecular Biology; Oncology; Pharmacology
Abstract
Triple negative breast cancer (TNBC) is an aggressive form of breast cancer that has a poor prognosis due to the high incidence of resistance to chemotherapy drugs. Drug resistance acquired in cancer cells is partly related to changes in cell metabolism and in gene regulation. Certain chemical changes that take place in DNA in the nucleus of the cell are called epigenetic changes and control which genes are expressed or not. These epigenetic processes are modulated by the availability of certain nutrients in the cell, called metabolites. While the availability of some of these metabolites can induce epigenetic changes and thus influence gene expression, epigenetic changes can in turn also control the levels and use of metabolites. This inter-regulation allows the tumour to adapt and survive in the context of a new environment, such as that resulting from exposure to drugs. The main objective of our research is to understand how metabolic and epigenetic changes regulate each other in drug-resistant TNBC in order to identify new ways to re-sensitize TNBC cells to chemotherapy. We have developed TNBC cells that are resistant to paclitaxel, a standard treatment drug for patients with TNBC. We are interested in understanding the role of methionine, an essential nutrient in the diet, in drug resistance. This is because drug resistant TNBC cells use more methionine than drug sensitive cells. We aim to identify how changes in methionine use in drug-resistant TNBC cells impact the production and use of other metabolites in order to identify potential vulnerabilities in resistant cells. We will also assess how these changes in methionine use contribute to altering epigenetic modifications and what the impact is on gene expression in paclitaxel-resistant TNBC cells.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Bouchard, Pascale
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~